Epitope specificity and isotype of monoclonal anti-D antibodies dictate their ability to inhibit phagocytosis of opsonized platelets
- 15 August 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (4), 1359-1361
- https://doi.org/10.1182/blood-2007-03-079848
Abstract
Rh immune globulin (WinRho SDF; Cangene, Mississauga, ON, Canada) is an effective treatment for autoimmune thrombocytopenic purpura; however, maintaining a sustained supply for its use in autoimmune thrombocytopenic purpura and its primary indication, hemolytic disease of the newborn, makes the development of alternative reagents desirable. We compared Rh immune globulin and 6 human monoclonal anti-D antibodies (MoAnti-D) with differing isotypes and specificities for their ability to opsonize erythrocytes and inhibit platelet phagocytosis in an in vitro assay. Results demonstrated that opsonization of erythrocytes with Rh immune globulin significantly (P < .001) reduced phagocytosis of fluorescently labeled opsonized platelets in an Fc-dependent manner. Of the MoAnti-D that shared specificity but differed in isotype, only IgG3 antibodies could significantly (P < .001) inhibit platelet phagocytosis. In contrast, 2 MoAnti-D shared isotypes and differed in specificity; however, only one could significantly (P < .001) inhibit platelet phagocytosis. The results suggest that MoAnti-D epitope specificity and isotypes are critical requirements for optimal inhibition of opsonized platelet phagocytosis.Keywords
This publication has 20 references indexed in Scilit:
- Platelet-bound lipopolysaccharide enhances Fc receptor–mediated phagocytosis of IgG-opsonized plateletsBlood, 2007
- Functional in vitro studies of recombinant human immunoglobulin G and immunoglobulin A anti-DTransfusion, 2007
- Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trialsTransfusion Clinique et Biologique, 2006
- A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcγRIIA and FcγIIIA genesBlood, 2004
- Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonistBlood, 2003
- Childhood chronic immune thrombocytopenic purpura (ITP)Blood Reviews, 2002
- The Treatment of Patients with Autoimmune Thrombocytopenia with Intravenous IgG‐Anti‐DVox Sanguinis, 1999
- Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-DTransfusion, 1996
- A Major Role of Class I Fcγ Receptors in Immunoglobulin G Anti-D--Mediated Red Blood Cell Destruction by Fetal Mononuclear PhagocytesObstetrics & Gynecology, 1995
- A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-DThe Journal of Pediatrics, 1992